{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:23:43Z","timestamp":1793831023303,"version":"4.6.1"},"reference-count":206,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-025-01544-2","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:06:34Z","timestamp":1743271594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9476-4770","authenticated-orcid":false,"given":"Shakila","family":"Yaribash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7699-8538","authenticated-orcid":false,"given":"Keyhan","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-5554","authenticated-orcid":false,"given":"Mahmood Alizadeh","family":"Sani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"1","key":"1544_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","volume":"25","author":"A Abeliovich","year":"2000","unstructured":"Abeliovich A, Schmitz Y, Fari\u00f1as I, Choi-Lundberg D, Ho W-H, Castillo PE, Shinsky N, Verdugo JMG, Armanini M, Ryan A (2000) Mice lacking \u03b1-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25(1):239\u2013252","journal-title":"Neuron"},{"issue":"2","key":"1544_CR2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ymthe.2017.11.015","volume":"26","author":"D Alarc\u00f3n-Ar\u00eds","year":"2018","unstructured":"Alarc\u00f3n-Ar\u00eds D, Recasens A, Galofr\u00e9 M, Carballo-Carbajal I, Zacchi N, Ruiz-Bronchal E, Pavia-Collado R, Chica R, Ferr\u00e9s-Coy A, Santos M, Revilla R, Montefeltro A, Fari\u00f1as I, Artigas F, Vila M, Bortolozzi A (2018) Selective \u03b1-synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for Parkinson\u2019s Disease. Mol Ther 26(2):550\u2013567. https:\/\/doi.org\/10.1016\/j.ymthe.2017.11.015","journal-title":"Mol Ther"},{"key":"1544_CR3","unstructured":"Phenylbutyrate Response As a Biomarker for Alpha-Synuclein Clearance From Brain (2014) https:\/\/clinicaltrials.gov\/study\/NCT02046434."},{"issue":"Pt 12","key":"1544_CR4","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1093\/brain\/aws289","volume":"135","author":"A Attar","year":"2012","unstructured":"Attar A, Ripoli C, Riccardi E, Maiti P, Li Puma DD, Liu T, Hayes J, Jones MR, Lichti-Kaiser K, Yang F, Gale GD, Tseng CH, Tan M, Xie CW, Straudinger JL, Kl\u00e4rner FG, Schrader T, Frautschy SA, Grassi C, Bitan G (2012) Protection of primary neurons and mouse brain from Alzheimer\u2019s pathology by molecular tweezers. Brain 135(Pt 12):3735\u20133748. https:\/\/doi.org\/10.1093\/brain\/aws289","journal-title":"Brain"},{"key":"1544_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2202-15-69","volume":"15","author":"S Auli\u0107","year":"2014","unstructured":"Auli\u0107 S, Le TT, Moda F, Abounit S, Corvaglia S, Casalis L, Gustincich S, Zurzolo C, Tagliavini F, Legname G (2014) Defined \u03b1-synuclein prion-like molecular assemblies spreading in cell culture. BMC Neurosci 15:69. https:\/\/doi.org\/10.1186\/1471-2202-15-69","journal-title":"BMC Neurosci"},{"issue":"11","key":"1544_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nm1102-1185","volume":"8","author":"PK Auluck","year":"2002","unstructured":"Auluck PK, Bonini NM (2002) Pharmacological prevention of Parkinson disease in Drosophila. Nat Med 8(11):1185\u20131186. https:\/\/doi.org\/10.1038\/nm1102-1185","journal-title":"Nat Med"},{"issue":"4","key":"1544_CR7","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1074\/jbc.M412106200","volume":"280","author":"PK Auluck","year":"2005","unstructured":"Auluck PK, Meulener MC, Bonini NM (2005) Mechanisms of suppression of \u03b1-synuclein neurotoxicity by geldanamycin in drosophila. J Biol Chem 280(4):2873\u20132878. https:\/\/doi.org\/10.1074\/jbc.M412106200","journal-title":"J Biol Chem"},{"issue":"8","key":"1544_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T (2005) Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord 11(8):493\u2013498. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.07.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"1544_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001884","volume":"3","author":"S Batelli","year":"2008","unstructured":"Batelli S, Albani D, Rametta R, Polito L, Prato F, Pesaresi M, Negro A, Forloni G (2008) DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson\u2019s disease and involvement of HSP70. PLoS ONE 3(4):e1884. https:\/\/doi.org\/10.1371\/journal.pone.0001884","journal-title":"PLoS ONE"},{"key":"1544_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1544_CR11","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH (2013) The function of \u03b1-synuclein. Neuron 79(6):1044\u20131066","journal-title":"Neuron"},{"issue":"1","key":"1544_CR12","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1038\/s41467-020-18689-x","volume":"11","author":"N Bengoa-Vergniory","year":"2020","unstructured":"Bengoa-Vergniory N, Faggiani E, Ramos-Gonzalez P, Kirkiz E, Connor-Robson N, Brown LV, Siddique I, Li Z, Vingill S, Cioroch M, Cavaliere F, Threlfell S, Roberts B, Schrader T, Kl\u00e4rner FG, Cragg S, Dehay B, Bitan G, Matute C, Bezard E, Wade-Martins R (2020) CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson\u2019s disease. Nat Commun 11(1):4885. https:\/\/doi.org\/10.1038\/s41467-020-18689-x","journal-title":"Nat Commun"},{"key":"1544_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnmol.2018.00036","volume":"11","author":"MJ Benskey","year":"2018","unstructured":"Benskey MJ, Sellnow RC, Sandoval IM, Sortwell CE, Lipton JW, Manfredsson FP (2018) Silencing alpha synuclein in mature nigral neurons results in rapid neuroinflammation and subsequent toxicity. Front Mol Neurosci 11:36","journal-title":"Front Mol Neurosci"},{"key":"1544_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102296","author":"MV Berezovski","year":"2024","unstructured":"Berezovski MV (2024) Breaking bad aggregates: How a DNA aptamer cleans up Parkinson\u2019s disease. Mol Ther Nucleic Acids. https:\/\/doi.org\/10.1016\/j.omtn.2024.102296","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"1544_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/mds.26481","volume":"31","author":"AL Bergstr\u00f6m","year":"2016","unstructured":"Bergstr\u00f6m AL, Kallunki P, Fog K (2016) Development of passive immunotherapies for Synucleinopathies. Mov Disord 31(2):203\u2013213. https:\/\/doi.org\/10.1002\/mds.26481","journal-title":"Mov Disord"},{"key":"1544_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nbd.2017.03.007","volume":"109","author":"G Bieri","year":"2018","unstructured":"Bieri G, Gitler AD, Brahic M (2018) Internalization, axonal transport and release of fibrillar forms of alpha-synuclein. Neurobiol Dis 109:219\u2013225","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1544_CR17","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1096\/fj.12-220657","volume":"27","author":"KJ Binger","year":"2013","unstructured":"Binger KJ, Ecroyd H, Yang S, Carver JA, Howlett GJ, Griffin MD (2013) Avoiding the oligomeric state: \u03b1B-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils. Faseb J 27(3):1214\u20131222. https:\/\/doi.org\/10.1096\/fj.12-220657","journal-title":"Faseb J"},{"issue":"10291","key":"1544_CR18","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. The Lancet 397(10291):2284\u20132303","journal-title":"The Lancet"},{"key":"1544_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3389\/fneur.2018.01021","volume":"9","author":"Book A, Guella I, Candido T, Brice A, Hattori N, Jeon B, Farrer MJ, Consortium SMIotG","year":"2018","unstructured":"Book A, Guella I, Candido T, Brice A, Hattori N, Jeon B, Farrer MJ, Consortium SMIotG (2018) A meta-analysis of \u03b1-synuclein multiplication in familial parkinsonism. Front Neurol 9:1021","journal-title":"Front Neurol"},{"issue":"11","key":"1544_CR20","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41594-019-0322-y","volume":"26","author":"DR Boyer","year":"2019","unstructured":"Boyer DR, Li B, Sun C, Fan W, Sawaya MR, Jiang L, Eisenberg DS (2019) Structures of fibrils formed by \u03b1-synuclein hereditary disease mutant H50Q reveal new polymorphs. Nat Struct Mol Biol 26(11):1044\u20131052","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"1544_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14207","volume":"143","author":"AK Braczynski","year":"2017","unstructured":"Braczynski AK, Schulz JB, Bach JP (2017) Vaccination strategies in tauopathies and synucleinopathies. J Neurochem 143(5):467\u2013488. https:\/\/doi.org\/10.1111\/jnc.14207","journal-title":"J Neurochem"},{"key":"1544_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1385\/JMN:28:2:179","volume":"28","author":"KA Brandis","year":"2006","unstructured":"Brandis KA, Holmes IF, England SJ, Sharma N, Kukreja L, DebBurman SK (2006) \u03b1-synuclein fission yeast model: Concentration\u2014Department aggregation without plasma membrane localization or toxicity. J Mol Neurosci 28:179\u2013191","journal-title":"J Mol Neurosci"},{"key":"1544_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2015.05.029","volume":"599","author":"S Brenner","year":"2015","unstructured":"Brenner S, Wersinger C, Gasser T (2015) Transcriptional regulation of the \u03b1-synuclein gene in human brain tissue. Neurosci Lett 599:140\u2013145","journal-title":"Neurosci Lett"},{"issue":"1","key":"1544_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/jci36470","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, Duyckaerts C, Flavell RA, Hirsch EC, Hunot S (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182\u2013192. https:\/\/doi.org\/10.1172\/jci36470","journal-title":"J Clin Invest"},{"issue":"10","key":"1544_CR25","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1002\/prot.23152","volume":"79","author":"IB Bruinsma","year":"2011","unstructured":"Bruinsma IB, Bruggink KA, Kinast K, Versleijen AA, Segers-Nolten IM, Subramaniam V, Kuiperij HB, Boelens W, de Waal RM, Verbeek MM (2011) Inhibition of \u03b1-synuclein aggregation by small heat shock proteins. Proteins 79(10):2956\u20132967. https:\/\/doi.org\/10.1002\/prot.23152","journal-title":"Proteins"},{"issue":"8","key":"1544_CR26","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/mds.27738","volume":"34","author":"M Brys","year":"2019","unstructured":"Brys M, Fanning L, Hung S, Ellenbogen A, Penner N, Yang M, Welch M, Koenig E, David E, Fox T, Makh S, Aldred J, Goodman I, Pepinsky B, Liu Y, Graham D, Weihofen A, Cedarbaum JM (2019) Randomized phase I clinical trial of anti-\u03b1-synuclein antibody BIIB054. Mov Disord 34(8):1154\u20131163. https:\/\/doi.org\/10.1002\/mds.27738","journal-title":"Mov Disord"},{"issue":"5999","key":"1544_CR27","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9 J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, S\u00fcdhof TC (2010) \u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329(5999):1663\u20131667","journal-title":"Science"},{"issue":"40","key":"1544_CR28","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","volume":"111","author":"J Burr\u00e9","year":"2014","unstructured":"Burr\u00e9 J, Sharma M, S\u00fcdhof TC (2014) \u03b1-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc Natl Acad Sci 111(40):E4274\u2013E4283","journal-title":"Proc Natl Acad Sci"},{"issue":"13","key":"1544_CR29","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1523\/JNEUROSCI.4650-14.2015","volume":"35","author":"J Burr\u00e9","year":"2015","unstructured":"Burr\u00e9 J, Sharma M, S\u00fcdhof TC (2015) Definition of a molecular pathway mediating \u03b1-synuclein neurotoxicity. J Neurosci 35(13):5221\u20135232","journal-title":"J Neurosci"},{"issue":"11","key":"1544_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165964","volume":"11","author":"DC Butler","year":"2016","unstructured":"Butler DC, Joshi SN, Genst E, Baghel AS, Dobson CM, Messer A (2016) Bifunctional anti-non-amyloid component \u03b1-synuclein nanobodies are protective in situ. PLoS ONE 11(11):e0165964. https:\/\/doi.org\/10.1371\/journal.pone.0165964","journal-title":"PLoS ONE"},{"issue":"1","key":"1544_CR31","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1038\/s41467-022-31787-2","volume":"13","author":"YR Butler","year":"2022","unstructured":"Butler YR, Liu Y, Kumbhar R, Zhao P, Gadhave K, Wang N, Li Y, Mao X, Wang W (2022) \u03b1-Synuclein fibril-specific nanobody reduces prion-like \u03b1-synuclein spreading in mice. Nat Commun 13(1):4060","journal-title":"Nat Commun"},{"issue":"6","key":"1544_CR32","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/mds.29784","volume":"39","author":"L Buur","year":"2024","unstructured":"Buur L, Wiedemann J, Larsen F, Ben Alaya-Fourati F, Kallunki P, Ditlevsen DK, S\u00f8rensen MH, Meulien D (2024) Randomized phase I trial of the \u03b1-synuclein antibody Lu AF82422. Mov Disord 39(6):936\u2013944. https:\/\/doi.org\/10.1002\/mds.29784","journal-title":"Mov Disord"},{"issue":"20","key":"1544_CR33","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","volume":"22","author":"DE Cabin","year":"2002","unstructured":"Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking \u03b1-synuclein. J Neurosci 22(20):8797\u20138807","journal-title":"J Neurosci"},{"issue":"15","key":"1544_CR34","doi-asserted-by":"publisher","first-page":"17185","DOI":"10.1021\/acsomega.3c10036","volume":"9","author":"T \u00c7amo\u011flu","year":"2024","unstructured":"\u00c7amo\u011flu T, Yurtta\u015f Z, K\u0131na \u00dcY, Akku\u015f S\u00fct P, Sahin F, Dursun E, Gezen-Ak D (2024) Fibrillar alpha-synuclein alters the intracellular chaperone levels within hours of its internalization. ACS Omega 9(15):17185\u201317194. https:\/\/doi.org\/10.1021\/acsomega.3c10036","journal-title":"ACS Omega"},{"issue":"1617","key":"1544_CR35","doi-asserted-by":"publisher","first-page":"20110409","DOI":"10.1098\/rstb.2011.0409","volume":"368","author":"S Carra","year":"2013","unstructured":"Carra S, Rusmini P, Crippa V, Giorgetti E, Boncoraglio A, Cristofani R, Naujock M, Meister M, Minoia M, Kampinga HH, Poletti A (2013) Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders. Philos Trans R Soc Lond B Biol Sci 368(1617):20110409. https:\/\/doi.org\/10.1098\/rstb.2011.0409","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"1544_CR36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/s0022-2836(02)00144-4","volume":"318","author":"JA Carver","year":"2002","unstructured":"Carver JA, Lindner RA, Lyon C, Canet D, Hernandez H, Dobson CM, Redfield C (2002) The interaction of the molecular chaperone alpha-crystallin with unfolding alpha-lactalbumin: a structural and kinetic spectroscopic study. J Mol Biol 318(3):815\u2013827. https:\/\/doi.org\/10.1016\/s0022-2836(02)00144-4","journal-title":"J Mol Biol"},{"issue":"1","key":"1544_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1379\/csc-236r.1","volume":"12","author":"S Chen","year":"2007","unstructured":"Chen S, Brown IR (2007) Neuronal expression of constitutive heat shock proteins: implications for neurodegenerative diseases. Cell Stress Chaperones 12(1):51\u201358. https:\/\/doi.org\/10.1379\/csc-236r.1","journal-title":"Cell Stress Chaperones"},{"issue":"6","key":"1544_CR38","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A (2005) Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease. Ann Neurol 58(6):963\u2013967","journal-title":"Ann Neurol"},{"issue":"9","key":"1544_CR39","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.21037\/qims-24-14","volume":"14","author":"F Chen","year":"2024","unstructured":"Chen F, Chen L, Cai G, Wang Y, Li Y, Xu H, Song W, Jian J, Chen X, Ye Q (2024) Association of synuclein alpha (SNCA) gene polymorphisms with spontaneous brain activity in patients with Parkinson\u2019s disease. Quant Imaging Med Surg 14(9):6806","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"1544_CR40","doi-asserted-by":"publisher","first-page":"C33","DOI":"10.1152\/ajpcell.00243.2006","volume":"292","author":"AJ Chicco","year":"2007","unstructured":"Chicco AJ, Sparagna GC (2007) Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 292(1):C33\u2013C44","journal-title":"Am J Physiol Cell Physiol"},{"key":"1544_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103256","volume":"147","author":"YH Choe","year":"2024","unstructured":"Choe YH, Jo MG, Kim BG, Lee S, Lee B, Kim SH, Seong H, Yoo WS, Kim M, Lee DK, Kim SJ, Yun SP, Kim M (2024) The autoimmune response induced by \u03b1-synuclein peptides drives neuronal cell death and glial cell activation. J Autoimmun 147:103256. https:\/\/doi.org\/10.1016\/j.jaut.2024.103256","journal-title":"J Autoimmun"},{"issue":"5","key":"1544_CR42","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1471-4159.2009.06250.x","volume":"110","author":"RL Clough","year":"2009","unstructured":"Clough RL, Dermentzaki G, Stefanis L (2009) Functional dissection of the \u03b1-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219. J Neurochem 110(5):1479\u20131490","journal-title":"J Neurochem"},{"issue":"2","key":"1544_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway KA, Lee S-J, Rochet J-C, Ding TT, Williamson RE, Lansbury PT Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc Natl Acad Sci 97(2):571\u2013576","journal-title":"Proc Natl Acad Sci"},{"key":"1544_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-4-9","volume":"4","author":"MR Cookson","year":"2009","unstructured":"Cookson MR (2009) \u03b1-Synuclein and neuronal cell death. Mol Neurodegener 4:1\u201314","journal-title":"Mol Neurodegener"},{"issue":"5688","key":"1544_CR45","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305(5688):1292\u20131295. https:\/\/doi.org\/10.1126\/science.1101738","journal-title":"Science"},{"issue":"LRRK2","key":"1544_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-319-49969-7_11","volume":"2","author":"JPL Daher","year":"2017","unstructured":"Daher JPL (2017) Interaction of LRRK2 and \u03b1-Synuclein in Parkinson\u2019s Disease. Leucine-Rich Repeat Kinase 2(LRRK2):209\u2013226","journal-title":"Leucine-Rich Repeat Kinase"},{"key":"1544_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106080","volume":"122","author":"KP del Giudice","year":"2024","unstructured":"del Giudice KP, Cosgaya M, Zaro I, Ravasi V, Santacruz P, Painous C, Fern\u00e1ndez M, C\u00e1mara A, Compta Y (2024) Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work? Parkinsonism Relat Disord 122:106080. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106080","journal-title":"Parkinsonism Relat Disord"},{"issue":"14","key":"1544_CR48","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of \u03b1-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283(14):9089\u20139100","journal-title":"J Biol Chem"},{"issue":"1","key":"1544_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13195-020-00743-x","volume":"13","author":"J Di","year":"2021","unstructured":"Di J, Siddique I, Li Z, Malki G, Hornung S, Dutta S, Hurst I, Ishaaya E, Wang A, Tu S, Boghos A, Ericsson I, Kl\u00e4rner FG, Schrader T, Bitan G (2021) The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice. Alzheimers Res Ther 13(1):6. https:\/\/doi.org\/10.1186\/s13195-020-00743-x","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"1544_CR50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E, Abbasi N, Abd-Allah F, Abdelalim A, Adsuar JC, Ansha MG, Brayne C, Choi J-YJ (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology 17(11):939\u2013953","journal-title":"The Lancet Neurology"},{"issue":"29","key":"1544_CR51","doi-asserted-by":"publisher","first-page":"8870","DOI":"10.1021\/bi034028+","volume":"42","author":"H-N Du","year":"2003","unstructured":"Du H-N, Tang L, Luo X-Y, Li H-T, Hu J, Zhou J-W, Hu H-Y (2003) A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human \u03b1-synuclein. Biochemistry 42(29):8870\u20138878","journal-title":"Biochemistry"},{"issue":"6","key":"1544_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001346","volume":"10","author":"ML Duennwald","year":"2012","unstructured":"Duennwald ML, Echeverria A, Shorter J (2012) Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans. PLoS Biol 10(6):e1001346. https:\/\/doi.org\/10.1371\/journal.pbio.1001346","journal-title":"PLoS Biol"},{"issue":"3","key":"1544_CR53","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1073\/pnas.1909110117","volume":"117","author":"RH Earls","year":"2020","unstructured":"Earls RH, Menees KB, Chung J, Gutekunst CA, Lee HJ, Hazim MG, Rada B, Wood LB, Lee JK (2020) NK cells clear \u03b1-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of \u03b1-synucleinopathy. Proc Natl Acad Sci U S A 117(3):1762\u20131771. https:\/\/doi.org\/10.1073\/pnas.1909110117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1544_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","volume":"74","author":"TL Edwards","year":"2010","unstructured":"Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Z\u00fcchner S, Konidari I, Wang G (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74(2):97\u2013109","journal-title":"Ann Hum Genet"},{"issue":"3","key":"1544_CR55","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1006\/bbrc.1997.7339","volume":"238","author":"RJ Ellis","year":"1997","unstructured":"Ellis RJ (1997) Do molecular chaperones have to be proteins? Biochem Biophys Res Commun 238(3):687\u2013692. https:\/\/doi.org\/10.1006\/bbrc.1997.7339","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"1544_CR56","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1016\/j.febslet.2006.04.057","volume":"580","author":"GH Fan","year":"2006","unstructured":"Fan GH, Zhou HY, Yang H, Chen SD (2006) Heat shock proteins reduce alpha-synuclein aggregation induced by MPP+ in SK-N-SH cells. FEBS Lett 580(13):3091\u20133098. https:\/\/doi.org\/10.1016\/j.febslet.2006.04.057","journal-title":"FEBS Lett"},{"issue":"1","key":"1544_CR57","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/epigenomes7010005","volume":"7","author":"EY Fedotova","year":"2023","unstructured":"Fedotova EY, Iakovenko EV, Abramycheva NY, Illarioshkin SN (2023) SNCA gene methylation in Parkinson\u2019s disease and multiple system atrophy. Epigenomes 7(1):5","journal-title":"Epigenomes"},{"issue":"7","key":"1544_CR58","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"S-M Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad S-M, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140(7):1959\u20131976","journal-title":"Brain"},{"key":"1544_CR59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2018.00247","volume":"12","author":"SA Ferreira","year":"2018","unstructured":"Ferreira SA, Romero-Ramos M (2018) Microglia response during Parkinson\u2019s disease: alpha-synuclein intervention. Front Cell Neurosci 12:247","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1544_CR60","doi-asserted-by":"publisher","first-page":"1994690","DOI":"10.1080\/19420862.2021.1994690","volume":"13","author":"L Fjord-Larsen","year":"2021","unstructured":"Fjord-Larsen L, Thougaard A, Wegener KM, Christiansen J, Larsen F, Schr\u00f8der-Hansen LM, Kaarde M, Ditlevsen DK (2021) Nonclinical safety evaluation, pharmacokinetics, and target engagement of Lu AF82422, a monoclonal IgG1 antibody against alpha-synuclein in development for treatment of synucleinopathies. Mabs 13(1):1994690. https:\/\/doi.org\/10.1080\/19420862.2021.1994690","journal-title":"Mabs"},{"issue":"28","key":"1544_CR61","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1523\/jneurosci.5314-13.2014","volume":"34","author":"D Games","year":"2014","unstructured":"Games D, Valera E, Spencer B, Rockenstein E, Mante M, Adame A, Patrick C, Ubhi K, Nuber S, Sacayon P, Zago W, Seubert P, Barbour R, Schenk D, Masliah E (2014) Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson\u2019s Disease-like models. J Neurosci 34(28):9441\u20139454. https:\/\/doi.org\/10.1523\/jneurosci.5314-13.2014","journal-title":"J Neurosci"},{"issue":"5","key":"1544_CR62","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","volume":"59","author":"X Gao","year":"2015","unstructured":"Gao X, Carroni M, Nussbaum-Krammer C, Mogk A, Nillegoda NB, Szlachcic A, Guilbride DL, Saibil HR, Mayer MP, Bukau B (2015) Human Hsp70 disaggregase reverses Parkinson\u2019s-linked \u03b1-synuclein amyloid fibrils. Mol Cell 59(5):781\u2013793. https:\/\/doi.org\/10.1016\/j.molcel.2015.07.012","journal-title":"Mol Cell"},{"key":"1544_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2001-3-1-reviews3002","volume":"3","author":"JM George","year":"2001","unstructured":"George JM (2001) The synucleins. Genome Biol 3:1\u20136","journal-title":"Genome Biol"},{"issue":"4","key":"1544_CR64","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson BI, Murray IV, Trojanowski JQ, Lee VM-Y (2001) A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-synuclein is essential for filament assembly. J Biol Chem 276(4):2380\u20132386","journal-title":"J Biol Chem"},{"issue":"8","key":"1544_CR65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(23)00205-3","volume":"22","author":"N Giladi","year":"2023","unstructured":"Giladi N, Alcalay RN, Cutter G, Gasser T, Gurevich T, H\u00f6glinger GU, Marek K, Pacchetti C, Schapira AHV, Scherzer CR, Simuni T, Minini P, Sardi SP, Peterschmitt MJ (2023) Safety and efficacy of venglustat in <em>GBA1<\/em>-associated Parkinson\u2019s disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet Neurol 22(8):661\u2013671. https:\/\/doi.org\/10.1016\/S1474-4422(23)00205-3","journal-title":"The Lancet Neurol"},{"issue":"6","key":"1544_CR66","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918\u2013934","journal-title":"Cell"},{"key":"1544_CR67","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10286-021-00829-y","volume":"31","author":"DS Goldstein","year":"2021","unstructured":"Goldstein DS, Isonaka R, Lamotte G, Kaufmann H (2021) Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies. Clin Auton Res 31:677","journal-title":"Clin Auton Res"},{"issue":"2","key":"1544_CR68","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/cne.20323","volume":"479","author":"T Gonz\u00e1lez-Hern\u00e1ndez","year":"2004","unstructured":"Gonz\u00e1lez-Hern\u00e1ndez T, Barroso-Chinea P, de la Cruz MI, del Mar P-D, Rodr\u00edguez M (2004) Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J Comparative Neurol 479(2):198\u2013215","journal-title":"J Comparative Neurol"},{"issue":"3","key":"1544_CR69","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.3390\/ijms24032044","volume":"24","author":"Z Granek","year":"2023","unstructured":"Granek Z, Barczuk J, Siwecka N, Rozp\u0119dek-Kami\u0144ska W, Kucharska E, Majsterek I (2023) GBA1 gene mutations in \u03b1-Synucleinopathies\u2014molecular mechanisms underlying pathology and their clinical significance. Int J Mol Sci 24(3):2044","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1544_CR70","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ana.25557","volume":"86","author":"V Grozdanov","year":"2019","unstructured":"Grozdanov V, Bousset L, Hoffmeister M, Bliederhaeuser C, Meier C, Madiona K, Pieri L, Kiechle M, McLean PJ, Kassubek J (2019) Increased immune activation by pathologic \u03b1-synuclein in Parkinson\u2019s disease. Ann Neurol 86(4):593\u2013606","journal-title":"Ann Neurol"},{"issue":"9","key":"1544_CR71","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/sj.cdd.4401705","volume":"12","author":"Z Gu","year":"2005","unstructured":"Gu Z, Nakamura T, Yao D, Shi Z-Q, Lipton S (2005) Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson\u2019s disease. Cell Death Differ 12(9):1202","journal-title":"Cell Death Differ"},{"key":"1544_CR72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnana.2015.00017","volume":"9","author":"C Guardia-Laguarta","year":"2015","unstructured":"Guardia-Laguarta C, Area-Gomez E, Schon EA, Przedborski S (2015) Novel subcellular localization for \u03b1-synuclein: possible functional consequences. Front Neuroanat 9:17","journal-title":"Front Neuroanat"},{"issue":"9","key":"1544_CR73","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ng.642","volume":"42","author":"TH Hamza","year":"2010","unstructured":"Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease. Nat Genet 42(9):781\u2013785","journal-title":"Nat Genet"},{"issue":"3","key":"1544_CR74","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/1074-5521(95)90071-3","volume":"2","author":"H Han","year":"1995","unstructured":"Han H, Weinreb PH, Lansbury PT Jr (1995) The core Alzheimer\u2019s peptide NAC forms amyloid fibrils which seed and are seeded by \u03b2-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem Biol 2(3):163\u2013169","journal-title":"Chem Biol"},{"key":"1544_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev.med.55.091902.103607","volume":"55","author":"J Hardy","year":"2004","unstructured":"Hardy J (2004) Toward Alzheimer therapies based on genetic knowledge. Annu Rev Med 55:15\u201325. https:\/\/doi.org\/10.1146\/annurev.med.55.091902.103607","journal-title":"Annu Rev Med"},{"issue":"7356","key":"1544_CR76","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature10317","volume":"475","author":"FU Hartl","year":"2011","unstructured":"Hartl FU, Bracher A, Hayer-Hartl M (2011) Molecular chaperones in protein folding and proteostasis. Nature 475(7356):324\u2013332. https:\/\/doi.org\/10.1038\/nature10317","journal-title":"Nature"},{"key":"1544_CR77","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","volume":"9","author":"C Helmschrodt","year":"2017","unstructured":"Helmschrodt C, H\u00f6bel S, Sch\u00f6niger S, Bauer A, Bonicelli J, Gringmuth M, Fietz SA, Aigner A, Richter A, Richter F (2017) Polyethylenimine nanoparticle-mediated siRNA delivery to reduce \u03b1-synuclein expression in a model of Parkinson\u2019s Disease. Mol Ther Nucleic Acids 9:57\u201368. https:\/\/doi.org\/10.1016\/j.omtn.2017.08.013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"1544_CR78","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","volume":"22","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Cornblath EJ, Darwich A, Zhang B, Brown H, Gathagan RJ, Sandler RM, Bassett DS, Trojanowski JQ, Lee VM (2019) Spread of \u03b1-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nat Neurosci 22(8):1248\u20131257","journal-title":"Nat Neurosci"},{"issue":"4","key":"1544_CR79","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8(4):382\u2013397","journal-title":"Lancet Neurol"},{"issue":"6286","key":"1544_CR80","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352(6286):712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Science"},{"issue":"12","key":"1544_CR81","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","volume":"27","author":"M Izco","year":"2019","unstructured":"Izco M, Blesa J, Schleef M, Schmeer M, Porcari R, Al-Shawi R, Ellmerich S, de Toro M, Gardiner C, Seow Y, Reinares-Sebastian A, Forcen R, Simons JP, Bellotti V, Cooper JM, Alvarez-Erviti L (2019) Systemic exosomal delivery of shRNA minicircles prevents Parkinsonian pathology. Mol Ther 27(12):2111\u20132122. https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.010","journal-title":"Mol Ther"},{"issue":"4","key":"1544_CR82","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/07853899908995889","volume":"31","author":"M J\u00e4\u00e4ttel\u00e4","year":"1999","unstructured":"J\u00e4\u00e4ttel\u00e4 M (1999) Heat shock proteins as cellular lifeguards. Ann Med 31(4):261\u2013271. https:\/\/doi.org\/10.3109\/07853899908995889","journal-title":"Ann Med"},{"issue":"42","key":"1544_CR83","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","volume":"110","author":"S Janezic","year":"2013","unstructured":"Janezic S, Threlfell S, Dodson PD, Dowie MJ, Taylor TN, Potgieter D, Parkkinen L, Senior SL, Anwar S, Ryan B (2013) Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci 110(42):E4016\u2013E4025","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"1544_CR84","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2018.1487","volume":"75","author":"J Jankovic","year":"2018","unstructured":"Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG (2018) Safety and tolerability of multiple ascending doses of PRX002\/RG7935, an anti-\u03b1-synuclein monoclonal antibody, in patients with Parkinson Disease: a randomized clinical trial. JAMA Neurol 75(10):1206\u20131214. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1487","journal-title":"JAMA Neurol"},{"issue":"5","key":"1544_CR85","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1021\/acs.biochem.7b01090","volume":"57","author":"NN Jha","year":"2018","unstructured":"Jha NN, Ranganathan S, Kumar R, Mehra S, Panigrahi R, Navalkar A, Ghosh D, Kumar A, Padinhateeri R, Maji SK (2018) Complexation of NAC-derived peptide ligands with the C-terminus of \u03b1-synuclein accelerates its aggregation. Biochemistry 57(5):791\u2013804. https:\/\/doi.org\/10.1021\/acs.biochem.7b01090","journal-title":"Biochemistry"},{"issue":"18","key":"1544_CR86","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","volume":"30","author":"A Jowaed","year":"2010","unstructured":"Jowaed A, Schmitt I, Kaut O, W\u00fcllner U (2010) Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains. J Neurosci 30(18):6355\u20136359","journal-title":"J Neurosci"},{"issue":"9996","key":"1544_CR87","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. The Lancet 386(9996):896\u2013912","journal-title":"The Lancet"},{"issue":"1","key":"1544_CR88","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12192-008-0068-7","volume":"14","author":"HH Kampinga","year":"2009","unstructured":"Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME, Chen B, Hightower LE (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14(1):105\u2013111. https:\/\/doi.org\/10.1007\/s12192-008-0068-7","journal-title":"Cell Stress Chaperones"},{"issue":"11","key":"1544_CR89","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.ymthe.2018.08.019","volume":"26","author":"B Kantor","year":"2018","unstructured":"Kantor B, Tagliafierro L, Gu J, Zamora ME, Ilich E, Grenier C, Huang ZY, Murphy S, Chiba-Falek O (2018) Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for precision therapy in PD. Mol Ther 26(11):2638\u20132649","journal-title":"Mol Ther"},{"key":"1544_CR90","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","volume":"327","author":"MN Karpenko","year":"2018","unstructured":"Karpenko MN, Vasilishina AA, Gromova EA, Muruzheva ZM, Bernadotte A (2018) Interleukin-1\u03b2, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell Immunol 327:77\u201382. https:\/\/doi.org\/10.1016\/j.cellimm.2018.02.011","journal-title":"Cell Immunol"},{"key":"1544_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105654","volume":"166","author":"A Kasen","year":"2022","unstructured":"Kasen A, Houck C, Burmeister AR, Sha Q, Brundin L, Brundin P (2022) Upregulation of \u03b1-synuclein following immune activation: Possible trigger of Parkinson\u2019s disease. Neurobiol Dis 166:105654. https:\/\/doi.org\/10.1016\/j.nbd.2022.105654","journal-title":"Neurobiol Dis"},{"issue":"7","key":"1544_CR92","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1212\/WNL.56.7.980","volume":"56","author":"H Kaufmann","year":"2001","unstructured":"Kaufmann H, Hague K, Perl D (2001) Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurology 56(7):980\u2013981","journal-title":"Neurology"},{"issue":"4","key":"1544_CR93","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon S-H, Kam T-I, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA (2019) Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103(4):627\u2013641","journal-title":"Neuron"},{"key":"1544_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113637","volume":"154","author":"S Kim","year":"2022","unstructured":"Kim S, Choi JG, Kim SW, Park SC, Kang YR, Park DS, Son M, Lee CH (2022) Inhibition of \u03b1-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson\u2019s disease. Biomed Pharmacother 154:113637. https:\/\/doi.org\/10.1016\/j.biopha.2022.113637","journal-title":"Biomed Pharmacother"},{"issue":"24","key":"1544_CR95","doi-asserted-by":"publisher","first-page":"25497","DOI":"10.1074\/jbc.M400255200","volume":"279","author":"J Klucken","year":"2004","unstructured":"Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ (2004) Hsp70 reduces alpha-synuclein aggregation and toxicity. J Biol Chem 279(24):25497\u201325502. https:\/\/doi.org\/10.1074\/jbc.M400255200","journal-title":"J Biol Chem"},{"issue":"1","key":"1544_CR96","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s12964-024-01791-8","volume":"22","author":"O Kosz\u0142a","year":"2024","unstructured":"Kosz\u0142a O, So\u0142ek P (2024) Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways. Cell Commun Signaling 22(1):421. https:\/\/doi.org\/10.1186\/s12964-024-01791-8","journal-title":"Cell Commun Signaling"},{"issue":"4","key":"1544_CR97","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneurol.2017.26","volume":"13","author":"F Krismer","year":"2017","unstructured":"Krismer F, Wenning GK (2017) Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat Rev Neurol 13(4):232\u2013243","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"1544_CR98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2012171118","volume":"118","author":"P Kumari","year":"2021","unstructured":"Kumari P, Ghosh D, Vanas A, Fleischmann Y, Wiegand T, Jeschke G, Riek R, Eichmann C (2021) Structural insights into \u03b1-synuclein monomer\u2013fibril interactions. Proc Natl Acad Sci 118(10):e2012171118","journal-title":"Proc Natl Acad Sci"},{"issue":"S1","key":"1544_CR99","first-page":"S180","volume":"36","author":"A Lang","year":"2021","unstructured":"Lang A, Siderowf A, Macklin E, Poewe W, Brooks D, Fernandez H, Rascol O, Giladi N, Stocchi F, Tanner C (2021) Cinpanemab in early Parkinson\u2019s disease: phase 2 SPARK study results. Mov Disord 36(S1):S180\u2013S181","journal-title":"Mov Disord"},{"issue":"5","key":"1544_CR100","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T (2022) Trial of Cinpanemab in early Parkinson\u2019s Disease. N Engl J Med 387(5):408\u2013420. https:\/\/doi.org\/10.1056\/NEJMoa2203395","journal-title":"N Engl J Med"},{"issue":"46","key":"1544_CR101","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1523\/JNEUROSCI.3821-06.2006","volume":"26","author":"KE Larsen","year":"2006","unstructured":"Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, Savalle M, Nemani V, Chaudhry FA, Edwards RH (2006) \u03b1-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci 26(46):11915\u201311922","journal-title":"J Neurosci"},{"issue":"1","key":"1544_CR102","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41467-018-03111-4","volume":"9","author":"J Lautenschl\u00e4ger","year":"2018","unstructured":"Lautenschl\u00e4ger J, Stephens AD, Fusco G, Str\u00f6hl F, Curry N, Zacharopoulou M, Michel CH, Laine R, Nespovitaya N, Fantham M (2018) C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction. Nat Commun 9(1):712","journal-title":"Nat Commun"},{"issue":"9","key":"1544_CR103","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1101\/gr.8.9.871","volume":"8","author":"C Lavedan","year":"1998","unstructured":"Lavedan C (1998) The synuclein family. Genome Res 8(9):871\u2013880","journal-title":"Genome Res"},{"issue":"11","key":"1544_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004741","volume":"10","author":"DF L\u00e1zaro","year":"2014","unstructured":"L\u00e1zaro DF, Rodrigues EF, Langohr R, Shahpasandzadeh H, Ribeiro T, Guerreiro P, Gerhardt E, Kr\u00f6hnert K, Klucken J, Pereira MD (2014) Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation. PLoS Genet 10(11):e1004741","journal-title":"PLoS Genet"},{"key":"1544_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-9-47","volume":"9","author":"J-Q Li","year":"2014","unstructured":"Li J-Q, Tan L, Yu J-T (2014) The role of the LRRK2 gene in Parkinsonism. Mol Neurodegener 9:1\u201317","journal-title":"Mol Neurodegener"},{"issue":"5","key":"1544_CR106","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-019-01974-5","volume":"137","author":"X Li","year":"2019","unstructured":"Li X, Koudstaal W, Fletcher L, Costa M, van Winsen M, Siregar B, Ingan\u00e4s H, Kim J, Keogh E, Macedo J, Holland T, Perry S, Bard F, Hoozemans JJ, Goudsmit J, Apetri A, Pascual G (2019) Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta Neuropathol 137(5):825\u2013836. https:\/\/doi.org\/10.1007\/s00401-019-01974-5","journal-title":"Acta Neuropathol"},{"key":"1544_CR107","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00115-017-0288-0","volume":"88","author":"C Lill","year":"2017","unstructured":"Lill C, Klein C (2017) Epidemiology and causes of Parkinson\u2019s disease. Nervenarzt 88:345\u2013355","journal-title":"Nervenarzt"},{"issue":"1","key":"1544_CR108","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","volume":"9","author":"MH Ludtmann","year":"2018","unstructured":"Ludtmann MH, Angelova PR, Horrocks MH, Choi ML, Rodrigues M, Baev AY, Berezhnov AV, Yao Z, Little D, Banushi B (2018) \u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease. Nat Commun 9(1):2293","journal-title":"Nat Commun"},{"issue":"1","key":"1544_CR109","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/s41598-018-19479-8","volume":"8","author":"J Magalhaes","year":"2018","unstructured":"Magalhaes J, Gegg ME, Migdalska-Richards A, Schapira AH (2018) Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons. Sci Rep 8(1):1385. https:\/\/doi.org\/10.1038\/s41598-018-19479-8","journal-title":"Sci Rep"},{"issue":"3","key":"1544_CR110","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1523\/JNEUROSCI.0680-22.2022","volume":"43","author":"CL Mahoney-Crane","year":"2023","unstructured":"Mahoney-Crane CL, Viswanathan M, Russell D, Curtiss RA, Freire J, Bobba SS, Coyle SD, Kandebo M, Yao L, Wan B-L (2023) Neuronopathic GBA1L444P mutation accelerates glucosylsphingosine levels and formation of hippocampal alpha-synuclein inclusions. J Neurosci 43(3):501\u2013521","journal-title":"J Neurosci"},{"key":"1544_CR111","doi-asserted-by":"crossref","unstructured":"Di Maio R, Barrett PJ, Hoffman EK, Barrett CW, Zharikov A, Borah A, Hu X, McCoy J, Chu CT, Burton EA (2016) \u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Science translational medicine 8 (342):342ra378\u2013342ra378","DOI":"10.1126\/scitranslmed.aaf3634"},{"key":"1544_CR112","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/978-1-4939-7811-3_24","volume":"1777","author":"R Malik","year":"2018","unstructured":"Malik R, Di J, Nair G, Attar A, Taylor K, Teng E, Kl\u00e4rner FG, Schrader T, Bitan G (2018) Using molecular tweezers to remodel abnormal protein self-assembly and inhibit the toxicity of amyloidogenic proteins. Methods Mol Biol 1777:369\u2013386. https:\/\/doi.org\/10.1007\/978-1-4939-7811-3_24","journal-title":"Methods Mol Biol"},{"issue":"5","key":"1544_CR113","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1021\/acs.molpharmaceut.4c00160","volume":"21","author":"M Matveyenka","year":"2024","unstructured":"Matveyenka M, Zhaliazka K, Kurouski D (2024) Macrophages and natural killers degrade \u03b1-synuclein aggregates. Mol Pharm 21(5):2565\u20132576. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00160","journal-title":"Mol Pharm"},{"issue":"1","key":"1544_CR114","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89(1):88\u2013100","journal-title":"Neurology"},{"issue":"4","key":"1544_CR115","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1471-4159.2002.01190.x","volume":"83","author":"PJ McLean","year":"2002","unstructured":"McLean PJ, Kawamata H, Shariff S, Hewett J, Sharma N, Ueda K, Breakefield XO, Hyman BT (2002) TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem 83(4):846\u2013854. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.01190.x","journal-title":"J Neurochem"},{"issue":"Pt 5","key":"1544_CR116","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/brain\/awu020","volume":"137","author":"A McNeill","year":"2014","unstructured":"McNeill A, Magalhaes J, Shen C, Chau KY, Hughes D, Mehta A, Foltynie T, Cooper JM, Abramov AY, Gegg M, Schapira AH (2014) Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain 137(Pt 5):1481\u20131495. https:\/\/doi.org\/10.1093\/brain\/awu020","journal-title":"Brain"},{"issue":"11","key":"1544_CR117","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/mds.28218","volume":"35","author":"WG Meissner","year":"2020","unstructured":"Meissner WG, Traon AP, Foubert-Samier A, Galabova G, Galitzky M, Kutzelnigg A, Laurens B, L\u00fchrs P, Medori R, P\u00e9ran P, Sabatini U, Vergnet S, Volc D, Poewe W, Schneeberger A, Staffler G, Rascol O (2020) A phase 1 randomized trial of specific active \u03b1-synuclein immunotherapies PD01A and PD03A in multiple system atrophy. Mov Disord 35(11):1957\u20131965. https:\/\/doi.org\/10.1002\/mds.28218","journal-title":"Mov Disord"},{"issue":"5","key":"1544_CR118","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ana.24790","volume":"80","author":"A Migdalska-Richards","year":"2016","unstructured":"Migdalska-Richards A, Daly L, Bezard E, Schapira AH (2016) Ambroxol effects in glucocerebrosidase and \u03b1-synuclein transgenic mice. Ann Neurol 80(5):766\u2013775. https:\/\/doi.org\/10.1002\/ana.24790","journal-title":"Ann Neurol"},{"issue":"6354","key":"1544_CR119","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"357","author":"S Mittal","year":"2017","unstructured":"Mittal S, Bj\u00f8rnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Sch\u00fcle B, Park DS, Riise T, Scherzer CR (2017) \u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson\u2019s disease. Science 357(6354):891\u2013898. https:\/\/doi.org\/10.1126\/science.aaf3934","journal-title":"Science"},{"issue":"22","key":"1544_CR120","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1599207","volume":"21","author":"N Mizushima","year":"2007","unstructured":"Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22):2861\u20132873. https:\/\/doi.org\/10.1101\/gad.1599207","journal-title":"Genes Dev"},{"issue":"4","key":"1544_CR121","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","volume":"77","author":"S Mullin","year":"2020","unstructured":"Mullin S, Smith L, Lee K, D\u2019Souza G, Woodgate P, Elflein J, H\u00e4llqvist J, Toffoli M, Streeter A, Hosking J, Heywood WE, Khengar R, Campbell P, Hehir J, Cable S, Mills K, Zetterberg H, Limousin P, Libri V, Foltynie T, Schapira AHV (2020) Ambroxol for the treatment of patients with parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized. Noncontrolled Trial JAMA Neurol 77(4):427\u2013434. https:\/\/doi.org\/10.1001\/jamaneurol.2019.4611","journal-title":"Noncontrolled Trial JAMA Neurol"},{"key":"1544_CR122","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuroscience.2011.10.042","volume":"200","author":"G Muntan\u00e9","year":"2012","unstructured":"Muntan\u00e9 G, Ferrer I, Martinez-Vicente M (2012) \u03b1-synuclein phosphorylation and truncation are normal events in the adult human brain. Neuroscience 200:106\u2013119","journal-title":"Neuroscience"},{"issue":"9","key":"1544_CR123","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","volume":"20","author":"DD Murphy","year":"2000","unstructured":"Murphy DD, Rueter SM, Trojanowski JQ, Lee VM-Y (2000) Synucleins are developmentally expressed, and \u03b1-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20(9):3214\u20133220","journal-title":"J Neurosci"},{"issue":"25","key":"1544_CR124","doi-asserted-by":"publisher","first-page":"22680","DOI":"10.1074\/jbc.M101181200","volume":"276","author":"MS Nielsen","year":"2001","unstructured":"Nielsen MS, Vorum H, Lindersson E, Jensen PH (2001) Ca2+ binding to \u03b1-synuclein regulates ligand binding and oligomerization. J Biol Chem 276(25):22680\u201322684","journal-title":"J Biol Chem"},{"issue":"1","key":"1544_CR125","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-\u017dugich","year":"2018","unstructured":"Nikolich-\u017dugich J (2018) The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol 19(1):10\u201319. https:\/\/doi.org\/10.1038\/s41590-017-0006-x","journal-title":"Nat Immunol"},{"key":"1544_CR126","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.parkreldis.2020.11.001","volume":"81","author":"K Nishioka","year":"2020","unstructured":"Nishioka K, Hashizume Y, Takanashi M, Daida K, Li Y, Yoshino H, Tambasco N, Prontera P, Hattori Y, Ueda A (2020) Pathological findings in a patient with alpha-synuclein p. A53T and familial Parkinson\u2019s disease. Parkinsonism Relat Disord 81:183\u2013187","journal-title":"Parkinsonism Relat Disord"},{"key":"1544_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105543","volume":"161","author":"E Nordstr\u00f6m","year":"2021","unstructured":"Nordstr\u00f6m E, Eriksson F, Sigvardson J, Johannesson M, Kasrayan A, Jones-Kostalla M, Appelkvist P, S\u00f6derberg L, Nygren P, Blom M, Rachalski A, Nordenankar K, Zachrisson O, Amandius E, Osswald G, Moge M, Ingelsson M, Bergstr\u00f6m J, Lannfelt L, M\u00f6ller C, Giorgetti M, F\u00e4lting J (2021) ABBV-0805, a novel antibody selective for soluble aggregated \u03b1-synuclein, prolongs lifespan and prevents buildup of \u03b1-synuclein pathology in mouse models of Parkinson\u2019s disease. Neurobiol Dis 161:105543. https:\/\/doi.org\/10.1016\/j.nbd.2021.105543","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1544_CR128","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Brundin P (2013) Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder? Mov Disord 28(1):31\u201340","journal-title":"Mov Disord"},{"issue":"11","key":"1544_CR129","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/brain\/awh625","volume":"128","author":"CF Orr","year":"2005","unstructured":"Orr CF, Rowe DB, Mizuno Y, Mori H, Halliday GM (2005) A possible role for humoral immunity in the pathogenesis of Parkinson\u2019s disease. Brain 128(11):2665\u20132674","journal-title":"Brain"},{"issue":"4","key":"1544_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001867","volume":"3","author":"TF Outeiro","year":"2008","unstructured":"Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ (2008) Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS ONE 3(4):e1867. https:\/\/doi.org\/10.1371\/journal.pone.0001867","journal-title":"PLoS ONE"},{"key":"1544_CR131","doi-asserted-by":"publisher","unstructured":"Padmanabhan J, Ratti E, Khudyakov P, Yin W, Zicha S, Golonzhka O, Kangarloo T, Harel B, Goodman N, Magueur E, Shering C, Ostenfeld T, Laurenza A, Simen A (2023) Study Design of TAK-341\u20132001: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of TAK-341 in subjects with multiple system atrophy (P9\u20139.003). Neurology 100 (17_supplement_2):0247. https:\/\/doi.org\/10.1212\/WNL.0000000000201834","DOI":"10.1212\/WNL.0000000000201834"},{"issue":"3","key":"1544_CR132","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/jpd-160867","volume":"6","author":"F Pagan","year":"2016","unstructured":"Pagan F, Hebron M, Valadez EH, Torres-Yaghi Y, Huang X, Mills RR, Wilmarth BM, Howard H, Dunn C, Carlson A, Lawler A, Rogers SL, Falconer RA, Ahn J, Li Z, Moussa C (2016) Nilotinib effects in Parkinson\u2019s disease and Dementia with Lewy bodies. J Parkinsons Dis 6(3):503\u2013517. https:\/\/doi.org\/10.3233\/jpd-160867","journal-title":"J Parkinsons Dis"},{"key":"1544_CR133","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.27.596130","author":"RG Parkinson","year":"2024","unstructured":"Parkinson RG, Xu T, Martin J, Xian Z, Ziko I, Pettitt JA, RCom-H\u2019Cheo-Forgues A, Buckland R, Gordon SL, Parish C, Br\u00fcstle A, Dehorter N (2024) \u0391lpha-synuclein induced immune response triggers Parkinson\u2019s Disease-like symptoms. BioRxiv. https:\/\/doi.org\/10.1101\/2024.05.27.596130","journal-title":"BioRxiv"},{"issue":"10","key":"1544_CR134","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/mds.27136","volume":"32","author":"L Parnetti","year":"2017","unstructured":"Parnetti L, Paciotti S, Eusebi P, Dardis A, Zampieri S, Chiasserini D, Tasegian A, Tambasco N, Bembi B, Calabresi P (2017) Cerebrospinal fluid \u03b2-glucocerebrosidase activity is reduced in Parkinson\u2019s disease patients. Mov Disord 32(10):1423\u20131431","journal-title":"Mov Disord"},{"issue":"6","key":"1544_CR135","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0896-6273(02)01125-X","volume":"36","author":"L Petrucelli","year":"2002","unstructured":"Petrucelli L, O\u2019Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J (2002) Parkin protects against the toxicity associated with mutant \u03b1-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36(6):1007\u20131019","journal-title":"Neuron"},{"issue":"22","key":"1544_CR136","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1111\/j.1742-4658.2007.06117.x","volume":"274","author":"AV Pivovarova","year":"2007","unstructured":"Pivovarova AV, Chebotareva NA, Chernik IS, Gusev NB, Levitsky DI (2007) Small heat shock protein Hsp27 prevents heat-induced aggregation of F-actin by forming soluble complexes with denatured actin. Febs J 274(22):5937\u20135948. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.06117.x","journal-title":"Febs J"},{"issue":"2","key":"1544_CR137","first-page":"205","volume":"59","author":"M Plaas","year":"2008","unstructured":"Plaas M, Karis A, Innos J, Rebane E, Baekelandt V, Vaarmann A, Luuk H, Vasar E, Koks S (2008) Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in ice. Acta Physiol Pol 59(2):205","journal-title":"Acta Physiol Pol"},{"key":"1544_CR138","first-page":"2014","volume":"6","author":"N Plotegher","year":"1840","unstructured":"Plotegher N, Gratton E (1840) Bubacco L (2014) Number and Brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells. Biochimica Et Biophysica Acta BBA-General Subjects 6:2014","journal-title":"Biochimica Et Biophysica Acta BBA-General Subjects"},{"key":"1544_CR139","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1146\/annurev.biochem.052308.114844","volume":"78","author":"ET Powers","year":"2009","unstructured":"Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78:959\u2013991. https:\/\/doi.org\/10.1146\/annurev.biochem.052308.114844","journal-title":"Annu Rev Biochem"},{"issue":"41","key":"1544_CR140","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1073\/pnas.1804198115","volume":"115","author":"J Pujols","year":"2018","unstructured":"Pujols J, Pe\u00f1a-D\u00edaz S, L\u00e1zaro DF, Peccati F, Pinheiro F, Gonz\u00e1lez D, Carija A, Navarro S, Conde-Gim\u00e9nez M, Garc\u00eda J, Guardiola S, Giralt E, Salvatella X, Sancho J, Sodupe M, Outeiro TF, Dalf\u00f3 E, Ventura S (2018) Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc Natl Acad Sci U S A 115(41):10481\u201310486. https:\/\/doi.org\/10.1073\/pnas.1804198115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1544_CR141","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/jpet.109.158436","volume":"332","author":"P Putcha","year":"2010","unstructured":"Putcha P, Danzer KM, Kranich LR, Scott A, Silinski M, Mabbett S, Hicks CD, Veal JM, Steed PM, Hyman BT, McLean PJ (2010) Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity. J Pharmacol Exp Ther 332(3):849\u2013857. https:\/\/doi.org\/10.1124\/jpet.109.158436","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"1544_CR142","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.4049\/jimmunol.1002449","volume":"186","author":"L Qian","year":"2011","unstructured":"Qian L, Wu HM, Chen SH, Zhang D, Ali SF, Peterson L, Wilson B, Lu RB, Hong JS, Flood PM (2011) \u03b22-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol 186(7):4443\u20134454. https:\/\/doi.org\/10.4049\/jimmunol.1002449","journal-title":"J Immunol"},{"issue":"1","key":"1544_CR143","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41531-023-00578-x","volume":"9","author":"M Ramezani","year":"2023","unstructured":"Ramezani M, Wagenknecht-Wiesner A, Wang T, Holowka DA, Eliezer D, Baird BA (2023) Alpha synuclein modulates mitochondrial Ca2+ uptake from ER during cell stimulation and under stress conditions. Npj Parkinson\u2019s Disease 9(1):137","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"1544_CR144","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fnmol.2016.00128","volume":"9","author":"A Recasens","year":"2016","unstructured":"Recasens A, Perier C, Sue CM (2016) Role of microRNAs in the regulation of \u03b1-synuclein expression: a systematic review. Front Mol Neurosci 9:128","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"1544_CR145","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jmb.2004.05.054","volume":"340","author":"A Rekas","year":"2004","unstructured":"Rekas A, Adda CG, Andrew Aquilina J, Barnham KJ, Sunde M, Galatis D, Williamson NA, Masters CL, Anders RF, Robinson CV, Cappai R, Carver JA (2004) Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity. J Mol Biol 340(5):1167\u20131183. https:\/\/doi.org\/10.1016\/j.jmb.2004.05.054","journal-title":"J Mol Biol"},{"issue":"24","key":"1544_CR146","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.1111\/j.1742-4658.2007.06144.x","volume":"274","author":"A Rekas","year":"2007","unstructured":"Rekas A, Jankova L, Thorn DC, Cappai R, Carver JA (2007) Monitoring the prevention of amyloid fibril formation by alpha-crystallin: Temperature dependence and the nature of the aggregating species. Febs J 274(24):6290\u20136304. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.06144.x","journal-title":"Febs J"},{"key":"1544_CR147","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s11064-013-1073-5","volume":"39","author":"HJ Rideout","year":"2014","unstructured":"Rideout HJ, Stefanis L (2014) The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson\u2019s disease. Neurochem Res 39:576\u2013592","journal-title":"Neurochem Res"},{"issue":"4","key":"1544_CR148","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/acn3.177","volume":"2","author":"EM Rocha","year":"2015","unstructured":"Rocha EM, Smith GA, Park E, Cao H, Brown E, Hallett P, Isacson O (2015) Progressive decline of glucocerebrosidase in aging and P arkinson\u2019s disease. Ann Clin Transl Neurol 2(4):433\u2013438","journal-title":"Ann Clin Transl Neurol"},{"key":"1544_CR149","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis 109:249\u2013257","journal-title":"Neurobiol Dis"},{"issue":"7","key":"1544_CR150","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/acn3.78","volume":"1","author":"I Rodr\u00edguez-Leyva","year":"2014","unstructured":"Rodr\u00edguez-Leyva I, Calder\u00f3n-Garcidue\u00f1as AL, Jim\u00e9nez-Capdeville ME, Renter\u00eda-Palomo AA, Hernandez-Rodriguez HG, Vald\u00e9s-Rodr\u00edguez R, Fuentes-Ahumada C, Torres-\u00c1lvarez B, Sep\u00falveda-Saavedra J, Soto-Dom\u00ednguez A (2014) \u03b1-Synuclein inclusions in the skin of Parkinson\u2019s disease and parkinsonism. Ann Clin Transl Neurol 1(7):471\u2013478","journal-title":"Ann Clin Transl Neurol"},{"key":"1544_CR151","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2015.04.022","volume":"597","author":"NJ Rutherford","year":"2015","unstructured":"Rutherford NJ, Giasson BI (2015) The A53E \u03b1-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture. Neurosci Lett 597:43\u201348","journal-title":"Neurosci Lett"},{"issue":"10","key":"1544_CR152","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrm3658","volume":"14","author":"H Saibil","year":"2013","unstructured":"Saibil H (2013) Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol 14(10):630\u2013642. https:\/\/doi.org\/10.1038\/nrm3658","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1544_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-021-01281-9","volume":"9","author":"K Sano","year":"2021","unstructured":"Sano K, Iwasaki Y, Yamashita Y, Irie K, Hosokawa M, Satoh K, Mishima K (2021) Tyrosine 136 phosphorylation of \u03b1-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2. Acta Neuropathol Commun 9:1\u201317","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"1544_CR154","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1073\/pnas.1616152114","volume":"114","author":"SP Sardi","year":"2017","unstructured":"Sardi SP, Viel C, Clarke J, Treleaven CM, Richards AM, Park H, Olszewski MA, Dodge JC, Marshall J, Makino E, Wang B, Sidman RL, Cheng SH, Shihabuddin LS (2017) Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models. Proc Natl Acad Sci U S A 114(10):2699\u20132704. https:\/\/doi.org\/10.1073\/pnas.1616152114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1544_CR155","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.27414","volume":"33","author":"SP Sardi","year":"2018","unstructured":"Sardi SP, Cedarbaum JM, Brundin P (2018) Targeted therapies for Parkinson\u2019s disease: from genetics to the clinic. Mov Disord 33(5):684\u2013696","journal-title":"Mov Disord"},{"issue":"4","key":"1544_CR156","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","volume":"7","author":"JA Saunders","year":"2012","unstructured":"Saunders JA, Estes KA, Kosloski LM, Allen HE, Dempsey KM, Torres-Russotto DR, Meza JL, Santamaria PM, Bertoni JM, Murman DL, Ali HH, Standaert DG, Mosley RL, Gendelman HE (2012) CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease. J Neuroimmune Pharmacol 7(4):927\u2013938. https:\/\/doi.org\/10.1007\/s11481-012-9402-z","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"1544_CR157","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/mds.26878","volume":"32","author":"DB Schenk","year":"2017","unstructured":"Schenk DB, Koller M, Ness DK, Griffith SG, Grundman M, Zago W, Soto J, Atiee G, Ostrowitzki S, Kinney GG (2017) First-in-human assessment of PRX002, an anti-\u03b1-synuclein monoclonal antibody, in healthy volunteers. Mov Disord 32(2):211\u2013218. https:\/\/doi.org\/10.1002\/mds.26878","journal-title":"Mov Disord"},{"issue":"11","key":"1544_CR158","doi-asserted-by":"publisher","first-page":"948","DOI":"10.4161\/hv.6.11.13217","volume":"6","author":"A Schneeberger","year":"2010","unstructured":"Schneeberger A, Mandler M, Mattner F, Schmidt W (2010) AFFITOME\u00ae technology in neurodegenerative diseases: the doubling advantage. Hum Vaccin 6(11):948\u2013952. https:\/\/doi.org\/10.4161\/hv.6.11.13217","journal-title":"Hum Vaccin"},{"issue":"Suppl 1","key":"1544_CR159","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/s1353-8020(11)70006-2","volume":"18","author":"A Schneeberger","year":"2012","unstructured":"Schneeberger A, Mandler M, Mattner F, Schmidt W (2012) Vaccination for Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S11-13. https:\/\/doi.org\/10.1016\/s1353-8020(11)70006-2","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1544_CR160","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/mds.26377","volume":"31","author":"A Schneeberger","year":"2016","unstructured":"Schneeberger A, Tierney L, Mandler M (2016) Active immunization therapies for Parkinson\u2019s disease and multiple system atrophy. Mov Disord 31(2):214\u2013224. https:\/\/doi.org\/10.1002\/mds.26377","journal-title":"Mov Disord"},{"key":"1544_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104582","volume":"132","author":"DJ Schofield","year":"2019","unstructured":"Schofield DJ, Irving L, Calo L, Bogstedt A, Rees G, Nuccitelli A, Narwal R, Petrone M, Roberts J, Brown L, Cusdin F, Dosanjh B, Lloyd C, Dobson C, Gurrell I, Fraser G, McFarlane M, Rockenstein E, Spencer B, Masliah E, Spillantini MG, Tan K, Billinton A, Vaughan T, Chessell I, Perkinton MS (2019) Preclinical development of a high affinity \u03b1-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular \u03b1-synuclein and attenuate \u03b1-synuclein spreading in vivo. Neurobiol Dis 132:104582. https:\/\/doi.org\/10.1016\/j.nbd.2019.104582","journal-title":"Neurobiol Dis"},{"key":"1544_CR162","first-page":"67","volume":"4","author":"C Schulte","year":"2011","unstructured":"Schulte C, Gasser T (2011) Genetic basis of Parkinson\u2019s disease: inheritance, penetrance, and expression. Appl Clin Genet 4:67\u201380","journal-title":"Appl Clin Genet"},{"issue":"9","key":"1544_CR163","doi-asserted-by":"publisher","first-page":"110657","DOI":"10.1016\/j.isci.2024.110657","volume":"27","author":"V Secco","year":"2024","unstructured":"Secco V, Tiago T, Staats R, Preet S, Chia S, Vendruscolo M, Carra S (2024) HSPB6: A lipid-dependent molecular chaperone inhibits \u03b1-synuclein aggregation. iScience 27(9):110657. https:\/\/doi.org\/10.1016\/j.isci.2024.110657","journal-title":"iScience"},{"issue":"1","key":"1544_CR164","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/hmg\/ddm289","volume":"17","author":"C Settembre","year":"2007","unstructured":"Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C, Medina D, de Pablo R, Tacchetti C, Rubinsztein DC, Ballabio A (2007) A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17(1):119\u2013129. https:\/\/doi.org\/10.1093\/hmg\/ddm289","journal-title":"Hum Mol Genet"},{"issue":"7618","key":"1544_CR165","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O\u2019Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A (2016) The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537(7618):50\u201356. https:\/\/doi.org\/10.1038\/nature19323","journal-title":"Nature"},{"issue":"2","key":"1544_CR166","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1124\/pharmrev.122.000654","volume":"75","author":"H Shahpasand-Kroner","year":"2023","unstructured":"Shahpasand-Kroner H, Siddique I, Malik R, Linares GR, Ivanova MI, Ichida J, Weil T, M\u00fcnch J, Sanchez-Garcia E, Kl\u00e4rner FG, Schrader T, Bitan G (2023) Molecular tweezers: supramolecular hosts with broad-spectrum biological applications. Pharmacol Rev 75(2):263\u2013308. https:\/\/doi.org\/10.1124\/pharmrev.122.000654","journal-title":"Pharmacol Rev"},{"issue":"4","key":"1544_CR167","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00018-016-2340-9","volume":"74","author":"SK Sharma","year":"2017","unstructured":"Sharma SK, Priya S (2017) Expanding role of molecular chaperones in regulating \u03b1-synuclein misfolding; implications in Parkinson\u2019s disease. Cell Mol Life Sci 74(4):617\u2013629. https:\/\/doi.org\/10.1007\/s00018-016-2340-9","journal-title":"Cell Mol Life Sci"},{"issue":"25","key":"1544_CR168","doi-asserted-by":"publisher","first-page":"23727","DOI":"10.1074\/jbc.M503326200","volume":"280","author":"Y Shin","year":"2005","unstructured":"Shin Y, Klucken J, Patterson C, Hyman BT, McLean PJ (2005) The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem 280(25):23727\u201323734. https:\/\/doi.org\/10.1074\/jbc.M503326200","journal-title":"J Biol Chem"},{"key":"1544_CR169","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2147\/dddt.S198753","volume":"13","author":"W Shin","year":"2019","unstructured":"Shin W, Lim KS, Kim MK, Kim HS, Hong J, Jhee S, Kim J, Yoo S, Chung YT, Lee JM, Cho DY (2019) A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson\u2019s disease, in healthy volunteers. Drug des Devel Ther 13:1011\u20131022. https:\/\/doi.org\/10.2147\/dddt.S198753","journal-title":"Drug des Devel Ther"},{"issue":"17","key":"1544_CR170","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361(17):1651\u20131661","journal-title":"N Engl J Med"},{"key":"1544_CR171","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbi.2024.08.015","volume":"122","author":"V Sigutova","year":"2024","unstructured":"Sigutova V, Xiang W, Regensburger M, Winner B, Prots I (2024) Alpha-synuclein fine-tunes neuronal response to pro-inflammatory cytokines. Brain Behav Immun 122:216\u2013230. https:\/\/doi.org\/10.1016\/j.bbi.2024.08.015","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1544_CR172","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12883-019-1252-3","volume":"19","author":"CRA Silveira","year":"2019","unstructured":"Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH (2019) Ambroxol as a novel disease-modifying treatment for Parkinson\u2019s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. BMC Neurol 19(1):20. https:\/\/doi.org\/10.1186\/s12883-019-1252-3","journal-title":"BMC Neurol"},{"issue":"10","key":"1544_CR173","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/mds.29170","volume":"37","author":"JW Smit","year":"2022","unstructured":"Smit JW, Basile P, Prato MK, Detalle L, Mathy FX, Schmidt A, Lalla M, Germani M, Domange C, Biere AL, Bani M, Carson S, Genius J (2022) Phase 1\/1b studies of UCB0599, an oral inhibitor of \u03b1-synuclein misfolding, including a randomized study in Parkinson\u2019s Disease. Mov Disord 37(10):2045\u20132056. https:\/\/doi.org\/10.1002\/mds.29170","journal-title":"Mov Disord"},{"issue":"4","key":"1544_CR174","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5607\/en.2014.23.4.292","volume":"23","author":"D Snead","year":"2014","unstructured":"Snead D, Eliezer D (2014) Alpha-synuclein function and dysfunction on cellular membranes. Exp Neurobiol 23(4):292","journal-title":"Exp Neurobiol"},{"key":"1544_CR175","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nbd.2019.03.001","volume":"127","author":"B Spencer","year":"2019","unstructured":"Spencer B, Trinh I, Rockenstein E, Mante M, Florio J, Adame A, El-Agnaf OMA, Kim C, Masliah E, Rissman RA (2019) Systemic peptide mediated delivery of an siRNA targeting \u03b1-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease. Neurobiol Dis 127:163\u2013177. https:\/\/doi.org\/10.1016\/j.nbd.2019.03.001","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1544_CR176","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1006\/geno.1995.1063","volume":"27","author":"MG Spillantini","year":"1995","unstructured":"Spillantini MG, Goedert M, Divane A (1995) Assignment of human {alpha}-synuclein (SNCA) and {beta}-synuclein (SNCB) genes to chromosomes 4q21 and 5q35. Genomics 27(2):379","journal-title":"Genomics"},{"issue":"6645","key":"1544_CR177","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-Synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"11","key":"1544_CR178","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci 95(11):6469\u20136473","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1544_CR179","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jmb.2005.08.025","volume":"353","author":"R Stamler","year":"2005","unstructured":"Stamler R, Kapp\u00e9 G, Boelens W, Slingsby C (2005) Wrapping the alpha-crystallin domain fold in a chaperone assembly. J Mol Biol 353(1):68\u201379. https:\/\/doi.org\/10.1016\/j.jmb.2005.08.025","journal-title":"J Mol Biol"},{"issue":"1","key":"1544_CR180","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/brainsci13010150","volume":"13","author":"A Surguchov","year":"2023","unstructured":"Surguchov A (2023) \u03b1-synuclein and mechanisms of epigenetic regulation. Brain Sci 13(1):150","journal-title":"Brain Sci"},{"issue":"2","key":"1544_CR181","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18(2):101\u2013113","journal-title":"Nat Rev Neurosci"},{"key":"1544_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-017-0077-5","volume":"6","author":"P Sweeney","year":"2017","unstructured":"Sweeney P, Park H, Baumann M, Dunlop J, Frydman J, Kopito R, McCampbell A, Leblanc G, Venkateswaran A, Nurmi A (2017) Protein misfolding in neurodegenerative diseases: implications and strategies. Translational Neurodegeneration 6:1\u201313","journal-title":"Translational Neurodegeneration"},{"issue":"3","key":"1544_CR183","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bbrc.2018.11.200","volume":"508","author":"G Tanaka","year":"2019","unstructured":"Tanaka G, Yamanaka T, Furukawa Y, Kajimura N, Mitsuoka K, Nukina N (2019) Biochemical and morphological classification of disease-associated alpha-synuclein mutants aggregates. Biochem Biophys Res Commun 508(3):729\u2013734","journal-title":"Biochem Biophys Res Commun"},{"key":"1544_CR184","unstructured":"TretiakoffC (1919) Contribution \u00e0 l\u2019\u00e9tude de l\u2019anatomie pathologique du locus niger de Soemmering avec quelques d\u00e9ductions relatives \u00e0 la pathogenit\u00e9 des troubles du tonus musculaire et de la maladie de Parkinson. Paris; 1919."},{"issue":"23","key":"1544_CR185","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","volume":"90","author":"K Ueda","year":"1993","unstructured":"Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero D, Kondo J, Ihara Y, Saitoh T (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci 90(23):11282\u201311286","journal-title":"Proc Natl Acad Sci"},{"key":"1544_CR186","unstructured":"United Nations. Department of Economic and Social Affairs. World Population Prospects. World Population Prospects. 2023. https:\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/undesa_pd_2024_wpa2023-report.pdf. 2024"},{"issue":"12","key":"1544_CR187","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nsb722","volume":"8","author":"RL van Montfort","year":"2001","unstructured":"van Montfort RL, Basha E, Friedrich KL, Slingsby C, Vierling E (2001) Crystal structure and assembly of a eukaryotic small heat shock protein. Nat Struct Biol 8(12):1025\u20131030. https:\/\/doi.org\/10.1038\/nsb722","journal-title":"Nat Struct Biol"},{"issue":"28","key":"1544_CR188","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","volume":"34","author":"KJ Vargas","year":"2014","unstructured":"Vargas KJ, Makani S, Davis T, Westphal CH, Castillo PE, Chandra SS (2014) Synucleins regulate the kinetics of synaptic vesicle endocytosis. J Neurosci 34(28):9364\u20139376","journal-title":"J Neurosci"},{"issue":"1","key":"1544_CR189","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41531-022-00423-7","volume":"8","author":"GS Virdi","year":"2022","unstructured":"Virdi GS, Choi ML, Evans JR, Yao Z, Athauda D, Strohbuecker S, Nirujogi RS, Wernick AI, Pelegrina-Hidalgo N, Leighton C (2022) Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson\u2019s disease in midbrain dopaminergic neurons. Npj Parkinson\u2019s Dis 8(1):162","journal-title":"Npj Parkinson\u2019s Dis"},{"issue":"17\u201318","key":"1544_CR190","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.vaccine.2005.01.007","volume":"23","author":"CY Wang","year":"2005","unstructured":"Wang CY, Walfield AM (2005) Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications. Vaccine 23(17\u201318):2049\u20132056. https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.007","journal-title":"Vaccine"},{"key":"1544_CR191","unstructured":"Wang CY (2014) Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer\u2019s type. Google Patents,"},{"key":"1544_CR192","unstructured":"Wang CY (2022) Artificial promiscuous T helper cell epitopes that facilitate targeted antibody production with limited T cell inflammatory response. Google Patents,"},{"key":"1544_CR193","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.nbd.2018.10.016","volume":"124","author":"A Weihofen","year":"2019","unstructured":"Weihofen A, Liu Y, Arndt JW, Huy C, Quan C, Smith BA, Baeriswyl JL, Cavegn N, Senn L, Su L, Marsh G, Auluck PK, Montrasio F, Nitsch RM, Hirst WD, Cedarbaum JM, Pepinsky RB, Grimm J, Weinreb PH (2019) Development of an aggregate-selective, human-derived \u03b1-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson\u2019s disease models. Neurobiol Dis 124:276\u2013288. https:\/\/doi.org\/10.1016\/j.nbd.2018.10.016","journal-title":"Neurobiol Dis"},{"issue":"43","key":"1544_CR194","doi-asserted-by":"publisher","first-page":"13709","DOI":"10.1021\/bi961799n","volume":"35","author":"PH Weinreb","year":"1996","unstructured":"Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT (1996) NACP, a protein implicated in Alzheimer\u2019s disease and learning, is natively unfolded. Biochemistry 35(43):13709\u201313715","journal-title":"Biochemistry"},{"issue":"2","key":"1544_CR195","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3233\/jpd-230319","volume":"14","author":"MH Werner","year":"2024","unstructured":"Werner MH, Olanow CW, McGarry A, Meyer C, Kruger S, Klint C, Pellecchia J, Walaker S, Ereshefsky L, Blob L, Hassman H, Rodriguez C, Samara E, Safirstein B, Ellenbogen A (2024) A phase I, randomized, SAD, MAD, and PK study of risvodetinib in older adults and Parkinson\u2019s disease. J Parkinsons Dis 14(2):325\u2013334. https:\/\/doi.org\/10.3233\/jpd-230319","journal-title":"J Parkinsons Dis"},{"key":"1544_CR196","doi-asserted-by":"publisher","first-page":"1308577","DOI":"10.3389\/fnagi.2024.1308577","volume":"16","author":"AW Wolff","year":"2024","unstructured":"Wolff AW, Bidner H, Remane Y, Zimmer J, Aarsland D, Rascol O, Wyse RK, Hapfelmeier A, Lingor P (2024) Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson\u2019s disease (ROCK-PD). Front Aging Neurosci 16:1308577. https:\/\/doi.org\/10.3389\/fnagi.2024.1308577","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"1544_CR197","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/nm0602-600","volume":"8","author":"J Xu","year":"2002","unstructured":"Xu J, Kao S-Y, Lee FJ, Song W, Jin L-W, Yankner BA (2002) Dopamine-dependent neurotoxicity of \u03b1-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 8(6):600\u2013606","journal-title":"Nat Med"},{"issue":"3","key":"1544_CR198","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.neurobiolaging.2014.10.042","volume":"36","author":"W Xu","year":"2015","unstructured":"Xu W, Tan L, Yu J-T (2015) The link between the SNCA gene and parkinsonism. Neurobiol Aging 36(3):1505\u20131518","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1544_CR199","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbrc.2005.03.148","volume":"331","author":"F Yu","year":"2005","unstructured":"Yu F, Xu H, Zhuo M, Sun L, Dong A, Liu X (2005) Impairment of redox state and dopamine level induced by alpha-synuclein aggregation and the prevention effect of hsp70. Biochem Biophys Res Commun 331(1):278\u2013284. https:\/\/doi.org\/10.1016\/j.bbrc.2005.03.148","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1544_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","volume":"13","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kim D, Kim S, Kim S, Karuppagounder SS, Kwon SH, Lee S, Kam TI, Lee S, Ham S, Park JH, Dawson VL, Dawson TM, Lee Y, Ko HS (2018) \u03b1-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Mol Neurodegener 13(1):1. https:\/\/doi.org\/10.1186\/s13024-017-0233-5","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1544_CR201","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.b.30195","volume":"137","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, James M, Middleton FA, Davis RL (2005) Transcriptional analysis of multiple brain regions in Parkinson\u2019s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 137(1):5\u201316. https:\/\/doi.org\/10.1002\/ajmg.b.30195","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"3","key":"1544_CR202","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1073\/pnas.1905057117","volume":"117","author":"P Zhang","year":"2020","unstructured":"Zhang P, Park HJ, Zhang J, Junn E, Andrews RJ, Velagapudi SP, Abegg D, Vishnu K, Costales MG, Childs-Disney JL, Adibekian A, Moss WN, Mouradian MM, Disney MD (2020) Translation of the intrinsically disordered protein \u03b1-synuclein is inhibited by a small molecule targeting its structured mRNA. Proc Natl Acad Sci U S A 117(3):1457\u20131467. https:\/\/doi.org\/10.1073\/pnas.1905057117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1544_CR203","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s42003-022-03768-0","volume":"5","author":"C Zhang","year":"2022","unstructured":"Zhang C, Pei Y, Zhang Z, Xu L, Liu X, Jiang L, Pielak GJ, Zhou X, Liu M, Li C (2022) C-terminal truncation modulates \u03b1-Synuclein\u2019s cytotoxicity and aggregation by promoting the interactions with membrane and chaperone. Commun Biol 5(1):798","journal-title":"Commun Biol"},{"issue":"37","key":"1544_CR204","doi-asserted-by":"publisher","first-page":"39155","DOI":"10.1074\/jbc.M405456200","volume":"279","author":"Y Zhou","year":"2004","unstructured":"Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS, Aebersold RH, Zhang J (2004) Analysis of alpha-synuclein-associated proteins by quantitative proteomics. J Biol Chem 279(37):39155\u201339164. https:\/\/doi.org\/10.1074\/jbc.M405456200","journal-title":"J Biol Chem"},{"issue":"7","key":"1544_CR205","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","volume":"5","author":"J Zhu","year":"2024","unstructured":"Zhu J, Cui Y, Zhang J, Yan R, Su D, Zhao D, Wang A, Feng T (2024) Temporal trends in the prevalence of Parkinson\u2019s disease from 1980 to 2023: a systematic review and meta-analysis. The Lancet Healthy Longevity 5(7):e464\u2013e479. https:\/\/doi.org\/10.1016\/S2666-7568(24)00094-1","journal-title":"The Lancet Healthy Longevity"},{"issue":"9","key":"1544_CR206","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184040","volume":"12","author":"L Zondler","year":"2017","unstructured":"Zondler L, Kostka M, Garidel P, Heinzelmann U, Hengerer B, Mayer B, Weishaupt JH, Gillardon F, Danzer KM (2017) Proteasome impairment by \u03b1-synuclein. PLoS ONE 12(9):e0184040. https:\/\/doi.org\/10.1371\/journal.pone.0184040","journal-title":"PLoS ONE"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01544-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-025-01544-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01544-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:02:27Z","timestamp":1765537347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-025-01544-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":206,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1007\/s10571-025-01544-2","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This manuscript is a review paper, and no new data collection involving human participants was conducted. As such, no ethics approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animal Participants"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}],"article-number":"30"}}